The patient decides to proceed with the intra gastric balloon (IGB) and undergoes endoscopic placement of an Obera intra -gastric balloon.
. Which is the appropriate advice to give this patient prior to discharge?
The patient can expect to lose 20-30 % of her weight over the next year.
Try again! Expected weight loss is between 10-12% total body weight and 25 % excess body weight loss at12 months after intra gastric balloon placement. Total body weight loss of 20-30% is reported with laparoscopic gastric sleeve surgery and Roux en Y gastric bypass surgery.
She should take a daily PPI while the balloon is in place
Correct! There is a slightly increased risk of gastric ulceration and erosion related to intra -gastric balloon so the AGA recommends patients be placed on PPI prophylaxis while the balloon is in place.
She is at increased risk for colitis with IGB.
Incorrect! Acute pancreatitis, not colitis, is a rare adverse event associated with IGBs.
She should be tested for nutritional deficiencies today
Try again! The AGA recommends against peri-operative testing for nutritional deficiencies in patients undergoing IGB placement, but suggests daily adult dose supplementation of a multivitamin as there is a risk of developing magnesium, potassium, thiamine and folate deficiencies post IGB.
She will likely experience nausea and vomiting after balloon placement and should take prophylactic anti-emetics.
Correct! Over 30% of patients will experience nausea and vomiting after IGB placement. Fluid filled balloons are more frequently associated with symptoms and lower tolerability than gas filled balloons. The AGA recommends all patients be placed on an anti-emetic regimen for 2 weeks following IGB.
Click here to move on
nutribytes.org 